Developments in strain improvement technology evolutionary engineering of industrial microorganisms through gene, pathway, and genome shuffling

Natural Products: Drug Discovery and Therapeutic Medicine

Volumn , Issue , 2005, Pages 107-125

  Del Cardayré, Stephen B ^a  

^a R and D Project Development and Management   (United States)

Author keywords

directed evolution; Fermentation; metabolic engineering; natural products; shuffling; Streptomyces

Indexed keywords

EID: 80054034988     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-976-9_6     Document Type: Chapter

References (55)

1. Zazopoulos E, Huang K, Staffa A, et al. A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 2003;21:187-190.
2. Miao V, Coeffet-Le Gal MF, Brown D, Sinnemann S, Donaldson G, Davies J. Genetic approaches to harvesting lichen products. Trends Biotechnol 2001;19:349-355.
3. Seow KT, Meurer G, Gerlitz M, Wendt-Pienkowski E, Hutchinson CR, Davies J. A study of iterative type II polyketide synthases, using bacterial genes cloned from soil DNA: a means to access and use genes from uncultured microorganisms. J Bacteriol 1997;179:7360-7368.
4. Wang GY, Graziani E, Waters B, et al. Novel natural products from soil DNA libraries in a streptomycete host. Org Lett 2000;2:2401-2404.
5. Mikhailov VV, Kuznetsova TA, Eliakov GB. [Bioactive compounds from marine actinomycetes]. Bioorg Khim 1995;21:3-8.
6. Haygood MG, Schmidt EW, Davidson SK, Faulkner DJ. Microbial symbionts of marine invertebrates: opportunities for microbial biotechnology. J Mol Microbiol Biotechnol 1999;1:33-43.
7. Wagner-Dobler I, Beil W, Lang S, Meiners M, Laatsch H. Integrated approach to explore the potential of marine microorganisms for the production of bioactive metabolites. Adv Biochem Eng Biotechnol 2002;74:207-238.
8. Schloss PD, Handelsman J. Biotechnological prospects from metagenomics. Curr Opin Biotechnol 2003;14:303-310.
9. Cropp TA, Kim BS, Beck BJ, Yoon YJ, Sherman DH, Reynolds KA. Recent developments in the production of novel polyketides by combinatorial biosynthesis. Biotechnol Genet Eng Rev 2002;19:159-172.
10. Reeves CD. The enzymology of combinatorial biosynthesis. Crit Rev Biotechnol 2003;23:95-147.
11. Michels PC, Khmelnitsky YL, Dordick JS, Clark DS. Combinatorial biocatalysis: a natural approach to drug discovery. Trends Biotechnol 1998;16:210-215.
12. Rich JO, Michels PC, Khmelnitsky YL. Combinatorial biocatalysis. Curr Opin Chem Biol 2002;6:161-167.
13. Reisman RB. Economics. In: Demain AL, Davies JE (eds), Manual of Industrial Microbiology and Bitechnology. Second edition. American Society of Microbiology, Washington, DC: 1999:273-288.
14. Aharonowitz Y, Cohen G. The microbiological production of pharmaceuticals. Sci Am 1981;245:141-152.
15. Askenazi M, Driggers EM, Holtzman DA, et al. Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains. Nat Biotechnol 2003;21:150-156.
16. Baltz RH, McHenney MA, Cantwell CA, Queener SW, Solenberg PJ. Applications of transposition mutagenesis in antibiotic producing streptomycetes. Antonie Van Leeuwenhoek 1997;71:179-187.
17. de Graaf AA, Eggeling L, Sahm H. Metabolic engineering for L-lysine production by Corynebacterium glutamicum. Adv Biochem Eng Biotechnol 2001;73:9-29.
18. Paradkar AS, Mosher RH, Anders C, et al. Applications of gene replacement technology to Streptomyces clavuligerus strain development for clavulanic acid production. Appl Environ Microbiol 2001;67:2292-2297.
19. Ohnishi J, Mitsuhashi S, Hayashi M, et al. A novel methodology employing Corynebacterium glutamicum genome information to generate a new L-lysine-producing mutant. Appl Microbiol Biotechnol 2002;58:217-223.
20. Queener SW, Lively DH. Screening and selection for strain improvement. In: Demain AL, Solomon NA (eds), Manual of Industrial Microbiology and Biotechnology. American Society of Microbiology, Washington, DC: 1986;155-169.
21. Baltz RH. Mutagenesis in Streptomyces spp. In: Demain AL, Solomon NA (eds), Manual of Industrial Microbiology and Biotechnology. American Society for Microbiology, Washington, DC: 1986;184-190.
22. Baltz RH. Molecular genetic approaches to yield improvement in actinomycetes. In: Strohl W R (ed), Biotechnology of Antibiotics. Vol 82. second ed. Marcel Dekker, New York: 1997:49-62.
23. Vinci VA, Byng G. Strain improvement by non-recombinant methods. In: Demain AL, Davies JE (eds), Manual of Industrial Microbiology and Biotechnology. 2 ed. ASM, Washington, DC: 1999;103-113.
24. Ellington AD, Szostak JW. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 1992:355:850-852.
25. Bartel DP, Szostak JW. Isolation of new ribozymes from a large pool of random sequences [see comment]. Science 1993;261:1411-1418.
26. Chapman KB, Szostak JW. In vitro selection of catalytic RNAs. Curr Opin Struct Biol 1994;4:618-622.
27. Stemmer WP. DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc Natl Acad Sci USA 1994;91:10, 747-10, 751.
28. Stemmer WP. Rapid evolution of a protein in vitro by DNA shuffling. Nature 1994;370:389-391.
29. Crameri A, Raillard SA, Bermudez E, Stemmer WP. DNA shuffling of a family of genes from diverse species accelerates directed evolution. Nature 1998;391:288-291.
30. Ness JE, Welch M, Giver L, et al. DNA shuffling of subgenomic sequences of subtilisin. Nat Biotechnol 1999;17:893-896.
31. Ness JE, Kim S, Gottman A, et al. Synthetic shuffling expands functional protein diversity by allowing amino acids to recombine independently. Nat Biotechnol 2002;20:1251-1255.
32. Govindarajan S, Ness JE, Kim S, Mundorff EC, Minshull J, Gustafsson C. Systematic variation of amino acid substitutions for stringent assessment of pairwise covariation. J Mol Biol 2003;328:1061-1069.
33. Gustafsson C, Govindarajan S, Emig R. Exploration of sequence space for protein engineering. J Mol Recognit 2001;14:308-314.
34. Zhang YX, Perry K, Vinci VA, Powell K, Stemmer WP, del Cardayre SB. Genome shuffling leads to rapid phenotypic improvement in bacteria. Nature 2002;415:644-646.
35. Patnaik R, Louie S, Gavrilovic V, et al. Genome shuffling of Lactobacillus for improved acid tolerance. Nat Biotechnol 2002;20:707-712.
36. Stutzman-Engwall K, Conlon S, Fedechko R, et al. Engineering the aveC gene to enhance the ratio of doramectin to its CHC-B2 analogue produced in Streptomyces avermitilis. Biotechnol Bioeng 2003;82:359-369.
37. Reetz MT. An overview of high-throughput screening systems for enantioselective enzymatic transformations. Methods Mol Biol 2003;230:259-282.
38. Minas W, Bailey JE, Duetz W. Streptomycetes in micro-cultures: growth, production of secondary metabolites, and storage and retrieval in the 96-well format. Antonie Van Leeuwenhoek 2000;78:297-305.
39. Duetz WA, Ruedi L, Hermann R, O'Connor K, Buchs J, Witholt B. Methods for intense aeration, growth, storage, and replication of bacterial strains in microtiter plates. Appl Environ Microbiol 2000;66:2641-2646.
40. Duetz WA, Witholt B. Effectiveness of orbital shaking for the aeration of suspended bacterial cultures in square-deepwell microtiter plates. Biochem Eng J 2001;7:113-115.
41. Maharbiz MM, Holtz WJ, Howe RT, Keasling JD. Microbioreactor arrays with parametric control for high-throughput experimentation. Biotechnol Bioeng 2004;85:376-381.
42. Powell KA, Ramer SW, Del Cardayre SB, et al. Directed evolution and biocatalysis. Angew Chem Int Ed Engl 2001;40:3948-3959.
43. Giver L, Arnold FH. Combinatorial protein design by in vitro recombination. Curr Opin Chem Biol 1998;2:335-338.
44. del Cardayre S, Powell K. DNA shuffling for whole cell engineering. In: Vinci VA, Parekh SR (eds), Handbook of Industrial Cell Culture. Humana, Totowa, New Jersey: 2003;465-482.
45. Ikeda H, Omura S. Avermectin biosynthesis. Chem Rev 1997;97:2591-2610.
46. Stutzman-Engwall KJ, Katoh Y, McArthur H A I, Stutzman-Engwall KJ, Katoh Y, McArthur H A I Stutzman-Engwall KJ, Katoh Y, McArthur H A Is; Pfizer, assignee. Streptomyces avermitilis gene directing the ratio of B1:B2 avermectins. US patent US6248579. June 19, 2001.
47. Stutzman-Engwall K, Conlon S, Fedechko R, et al. Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of Doramectin by Streptomyces avermitilis. Metab Eng 2004, in press.
48. Ran N, Draths KM, Frost JW. Creation of a shikimate pathway variant. J Am Chem Soc 2004, in press.
49. Crameri A, Dawes G, Rodriguez E, Jr., Silver S, Stemmer WP. Molecular evolution of an arsenate detoxification pathway by DNA shuffling. Nat Biotechnol 1997;15:436-438.
50. Newman L, Garcia H, Hudlickey T, Selifonov S. Directed evolution of the dioxygenase complex for the synthesis of furanone flavor compounds. Tetrahedron 2004;60:729-734.
51. Hopwood DA, Wright HM, Bibb MJ, Cohen SN. Genetic recombination through protoplast fusion in Streptomyces. Nature 1977;268:171-174.
52. Baltz RH. Genetic recombination in Streptomyces fradiae by protoplast fusion and cell regeneration. J Gen Microbiol 1978;107:93-102.
53. Hopwood DA, Wright HM. Bacterial protoplast fusion: recombination in fused protoplasts of Streptomyces coelicolor. Mol Gen Genet 1978;162:307-317.
54. Hopwood DA, Chater KF. Fresh approaches to antibiotic production. Philos Trans R Soc Lond B Biol Sci 1980;290:313-328.
55. Hopwood DA. The many faces of recombination. In: Sebek OK, Laskin AI (eds), Genetics of Industrial Microorganisms. Washington, DC: American Society for Microbiology. 1979:1-9.